Research Paper Volume 15, Issue 10 pp 4444—4464
Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma
Figure 6. The efficiency of the risk score and comprehensive score in predicting patient survival. (A–C) K-M analysis and ROC curves showed the prognostic value in training and validation cohorts. (D) The nomogram showed the prognostic value of clinicopathological parameters and risk score. (E) The calibration plots indicate the accuracy and specificity of the nomogram.